All Phage Therapy articles
-
NewsScientists find hidden individuality in viral infections
An international team of researchers developed a new way to uncover hidden differences in how viruses infect and destroy individual microbial cells—solving a biological puzzle that has persisted for more than 80 years.
-
NewsClinical trial aims to break the cycle of recurrent urinary tract infections with bacteria’s natural enemies
Researchers’ data-driven microbiological and phage therapy approaches may help move phage therapy beyond case-by-case experimental use toward a strategy that is predictable, measurable and clinically interpretable.
-
NewsResearchers use friendly viruses to tackle inflammatory bowel disease
A research team has developed a targeted approach to treating inflammatory bowel disease (IBD) using bacteriophages, viruses that infect specific bacteria, to disarm harmful microbes without disrupting the broader gut ecosystem.
-
NewsRNA barcoding approach reveals previously unknown virus-host relationships
Researchers have uncovered previously unknown relationships between bacteriophages and their bacterial hosts. They found a previously unreported group of bacterial hosts for the well-studied bacteriophage P1 and examine how subtle changes in viral structure influence which microbes a phage can target.
-
NewsMolecular anchors on gut phages may open new avenues for therapeutic development
A new study has identified phage surface proteins acting as molecular anchors. These proteins confer phages with the ability to attach to human cells. Using genetic engineering, the researchers transferred these adhesion proteins onto the surface of another phage that otherwise lacked this ability.
-
NewsScientists probe antiviral molecules in bacteria that target bacteriophages
Researchers have examined the antiviral molecule daunorubicin, produced by Streptomycetes, and decoded its mode of operation against viruses. They now describe this mechanism, which primarily targets a specific group of viruses – namely bacteriophages.
-
NewsThe future of phage therapy will be decided by more than science alone
As antimicrobial resistance accelerates worldwide, leading experts gather in Valencia to address the scientific, regulatory, manufacturing and clinical challenges that will determine whether phage therapy becomes a routine healthcare solution.
-
NewsGladstone launches Center for PhAIge Therapy to harness AI in the fight against drug-resistant infections
Gladstone Institutes has received funding to establish the Center for PhAIge Therapy, a research center that will develop new phage-based treatments for antibiotic-resistant bacterial infections. The five-year grant makes Gladstone one of three institutions across the country selected to lead this coordinated effort.
-
NewsProtection for newborns: New treatment aims to prevent meningitis without antibiotics
One of the leading pathogens responsible for meningitis cases in newborn babies is the K1 form of the E. coli bacterium. Now, researchers have developed a triple-pronged approach that seeks to prevent transmission to newborns.
-
NewsEstablishing a regulatory framework for phage therapy in China
A new study summarizes the current regulatory frameworks for phage therapy in Western countries and China, and proposes a pathway for establishing a regulatory framework that enables safe and effective clinical application of phage therapy in China.
-
NewsResearchers advance phage therapy in fight against antimicrobial resistance
Scientists have uncovered how Mycobacterium abscessus can evade bacteriophage therapy, and demonstrated a combination strategy to overcome this resistance, offering a pathway towards more effective and durable treatments.
-
NewsResearchers uncover three families of ‘sponge’ proteins deployed by phages
Using an innovative research approach that combines artificial intelligence with experimental biology, researchers have uncovered new families of sponge proteins in phage genomes that disrupt immune communication in bacteria.
-
NewsPhage therapy at a turning point: Valencia 2026 to define the next era of antibacterial medicine
The Targeting Phage Therapy 2026 Congress will bring together leading scientists, clinicians, microbiologists, engineers, biotech leaders, regulators, hospital teams, start-ups, and innovators to ask: How can phage therapy move from promising science to accessible, validated, and deployable medicine?
-
NewsResearchers deploy phage therapy in new frontier against antimicrobial resistant infectious diseases
A revelatory treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections.
-
NewsCall for evidence: Why has the promise of personalised medicine failed to materialise on the ground?
A new inquiry by the UK Parliament’s Science and Technology Committee investigates why the NHS adoption of the UK’s cutting-edge life sciences innovations often fails - and what could be done to fix it. Members of AMI could be just the people to provide answers.
-
NewsResearchers find a gentler way to treat aggressive gum disease
Researchers have discovered that the primary bacterium driving gum disease carries an internal “genetic brake” that controls its own aggression. By locking this brake in place, future treatments could silence the pathogen while leaving beneficial bacteria untouched.
-
NewsSilent enemies, smart weapons - switching off phage contamination using nanoparticles
Bacteriophages represent a serious threat to laboratories and industries that rely on bacterial cultures for production. Researchers have demonstrated an innovative solution that enables targeting the surface of bacteriophage through electrostatic interactions.
-
NewsNew study reveals a minimalist bacterial defense that disrupts viral assembly
Researchers describe how a single protein named Rip1 recognizes bacteriophages, the viruses that infect bacteria, and cause infected bacteria to die prematurely, thereby ending the chain of transmission.
-
NewsHow bacteria learned to target numerous cell types, revealed
A new study shows how bacteria adapted a virus-derived injection system to recognize and attach to many different types of cells. By identifying thousands of rapidly evolving receptor-binding proteins, the researchers explain how these systems can be retargeted in nature by swapping the part that binds to cells.
-
NewsPIXL Max: Automated colony picker breaks records for speed and accuracy
With the latest innovation from the team at Singer Instruments, a new standard for speed and repeatability in microbial colony pickers has been achieved through the integration of cutting edge AI technologies.